New Rapid-acting Antidepressants (Contemporary Clinical Neuroscience) - Image 1

£134.41

Springer New Rapid-acting Antidepressants (Contemporary Clinical Neuroscience)

Name: New Rapid-acting Antidepressants (Contemporary Clinical Neuroscience)
Brand: Springer
Price: 134.41 GBP
Availability: InStock

Neurology & Clinical Neurophysiology

This is the most expensive it has ever been. Walk away.

£134 today · previous high £134 · all-time low £123

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 448 days • 448 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 448 days • 6 price levels

Days at Price

Current Price

Price Analysis

Most common price: £123 (183 days, 40.8%)

Price range: £123 - £134

Price levels: 6 different prices over 448 days

Description

This book discusses new candidates for rapid-acting antidepressants, such as (R)-ketamine, (2R,6R)-hydroxynorketamine, scopolamine, mGluR2/3 antagonists and AMPA receptor agonists. There are serious limitations to currently available antidepressants, such as delayed onset and low rates of efficacy. The discovery that a single dose of ketamine, an NMDAR antagonist, can produce rapid antidepressant effects that are sustained has led to new research in this area. In this volume, a variety of novel pharmaceutical treatments are examined. This volume would be useful to both researchers and clinicians who work in the field of pharmacology, specifically CNS drug treatments. From the Back Cover This book discusses new candidates for rapid-acting antidepressants, such as (R)-ketamine, (2R,6R)-hydroxynorketamine, scopolamine, mGluR2/3 antagonists and AMPA receptor agonists. There are serious limitations to currently available antidepressants, such as delayed onset and low rates of efficacy. The discovery that a single dose of ketamine, an NMDAR antagonist, can produce rapid antidepressant effects that are sustained has led to new research in this area. In this volume, a variety of novel pharmaceutical treatments are examined. This volume would be useful to both researchers and clinicians who work in the field of pharmacology, specifically CNS drug treatments. Discusses new candidate for rapid-acting antidepressants Provides information for those who work in the field of CNS drugs Ideal for pharmacologists, psychiatrists, and those who want to learn about CNS drugs at the graduate level About the Author First Name – Kenji Last Name – Hashimoto Institution - Chiba University Center for Forensic Mental Health Department - Division of Clinical Neuroscience City – Chiba 260-8670 State – Chiba Country – Japan Email – hashimoto@faculty.chiba-u.jp Kenji Hashimoto, PhD Chiba University, Chiba, Japan Dr. Hashimoto is a professor and vice-director of Chiba University Center for Forensic Mental Health from 2005. Dr. Hashimoto graduated from Faculty of Pharmaceutical Sciences at Kyushu University, and received PhD. After Dr. Hashimoto worked at Fukuyama University, National Institutes of Health (NIH)/National Institute of Drug Addiction (NIDA)(Baltimore, MD, USA) and Pharmaceutical company, he moved at Chiba University Graduate School of Medicine from 2001. Dr. Hashimoto works on the development of novel therapeutic drugs for psychiatric and neurological disorders. Dr. Hashimoto published more than 550 articles in PubMed listed publications. Dr. Hashimoto focus on the molecular and cellular mechanisms of ketamine’s antidepressant actions.

Product Specifications

Brand: Springer
Format: hardcover
ASIN: 3030797899
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Internal Medicine > Neurology & Clinical Neurophysiology
Domain: Amazon UK
Release Date: 23 October 2021
Listed Since: 26 May 2021

Barcode

No barcode data available

Springer New Rapid-acting Antidepressants (Contemporary Clinical Neuroscience)

This is the most expensive it has ever been. Walk away.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Ketamine for Treatment-Resistant Depression: Neurobiology and Applications

Ketamine: Use and Abuse - CRC Press Medical Research Book

Ketamine: History, Uses and Health Effects

Kaplan & Sadock’s Pocket Handbook of Clinical Psychiatry

Interventional Psychiatry: Road to Novel Therapeutics

Clinical Handbook for the Management of Mood Disorders

Kaplan and Sadock’s Pocket Handbook of Psychiatric Drug Treatment

Ketamine for Treatment-Resistant Depression: The First Decade of Progress

Herbal Treatment of Major Depression: Scientific Basis and Practical Use (Clinical Pharmacognosy Series)

Molecular Psychiatry

Springer Understanding Depression Vol 2 - Clinical Management

Neuropsychopharmacology of the Trace Amines: Experimental and Clinical Aspects (Experimental and Clinical Neuroscience)

Neuropsychopharmacology of the Trace Amines: Experimental and Clinical Aspects (Experimental and Clinical Neuroscience)

Pharmacotherapy of Depression

Seminars in Clinical Psychopharmacology (College Seminars Series)

Drug Development in Psychiatry: 30 (Advances in Neurobiology, 30)

Psychopharmacology and Child Psychiatry Review: With 1200 Board-Style Questions

Difficult to Treat Depression: A Carlat Guide

Pediatric Psychopharmacology: Principles and Practice

Massachusetts General Hospital Psychopharmacology and Neurotherapeutics

Integrating Psychotherapy and Psychopharmacology: A Handbook for Clinicians (Clinical Topics in Psychology and Psychiatry)

Elektrokonvulsionstherapie kompakt: Für Zuweiser und Anwender

Serotonin Receptors in Neurobiology (Frontiers in Neuroscience)

5-HT Interaction with Other Neurotransmitters: Experimental Evidence and Therapeutic Relevance Part A (Volume 259) (Progress in Brain Research, Volume 259)